tVNS in Long COVID-19
50
about 2.2 years
21–70
1 site in NY
About this study
Researchers are testing a treatment called transcutaneous vagus nerve stimulation (tVNS) to see if it improves the health of people with long COVID. The trial will compare two different settings for the tVNS device and see which one works best over 6 weeks, with those who use their assigned device for at least 30 out of 42 opportunities receiving the best setting for another 6 weeks.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use Transcutaneous vagus nerve stimulator
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Primary: Change in Short Form Health Survey (SF-36), The Chalder Fatigue Questionnaire (CFQ), VAS measuring Postexertional malaise (PEM), VAS measuring brain fog, VAS to measure Widespread Pain, Visual Analog Scale (VAS) measuring Fatigue
Secondary: Heart Rate Variability (HRV)
therapeutic